FdaApplication
ANDA 212347
Identifiers
- fda_app_no: ANDA212347
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-09-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% | POTASSIUM CHLORIDE; SODIUM CHLORIDE | 150MG/100ML;450MG/100ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% | POTASSIUM CHLORIDE; SODIUM CHLORIDE | 150MG/100ML;900MG/100ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% | POTASSIUM CHLORIDE; SODIUM CHLORIDE | 300MG/100ML;900MG/100ML | INJECTABLE;INJECTION |
3 products